Adaptive Phage Therapeutics
Adaptive Phage Therapeutics is a phage treatments targeting multi-drug resistant bacteria founded in 2016 by Greg Merril.
7
Funding Rounds
$104.4m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca** Me**** | - | - | - |
| Gr** Me**** | - | - |
Funding series
Funding Series Analysis
The company Adaptive Phage Therapeutics has raised a total of $20m in funding over 7 rounds.
Key Insights:
- Adaptive Phage Therapeutics , April 2022: $20m
- Adaptive Phage Therapeutics Convertible note, June 2020: $6.2m
- Adaptive Phage Therapeutics Seed round, February 2017: $765k
- Adaptive Phage Therapeutics Grant (money), January 2020: $10.2m
- Adaptive Phage Therapeutics Debt Financing, January 2018: $7m
- Adaptive Phage Therapeutics Venture round, October 2019: $7m
- Adaptive Phage Therapeutics, Inc. funding round, May 2021: $53.26m
Adaptive Phage Therapeutics , April 2022
$20m
Adaptive Phage Therapeutics Convertible note, June 2020
$6.2m
Adaptive Phage Therapeutics Seed round, February 2017
$765k
Adaptive Phage Therapeutics Grant (money), January 2020
$10.2m
Adaptive Phage Therapeutics Debt Financing, January 2018
$7m
Adaptive Phage Therapeutics Venture round, October 2019
$7m
Adaptive Phage Therapeutics, Inc. funding round, May 2021
$53.26m
Industries
Adaptive Phage Therapeutics is active in the following industries: